Urdahl, Kevin
- Seattle Children's Hospital · Microbiology & Immunology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #128
- Top 1% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$14.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#128
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Urdahl, Kevin as a PI. Multi-PI records show the full award amount for context.
- 75N93019C00070-P00017-9999-1N01Contact PIIMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)Seattle Children's Hospital · Microbiology & Immunology (topic-inferred)$10.7Maward amount
- 75N93019C00070-P00017-9999-2N01Contact PIIMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTERSeattle Children's Hospital · Microbiology & Immunology (topic-inferred)$3.6Maward amount
Award organization
Organizations that administered FY2023 awards listing Urdahl, Kevin as a PI.
FY2023 award administered by Seattle Children's Hospital (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardSeattle Children's Hospital
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #111
- 2019Entered Top 25% NationallyRanked #111
- 2019Entered Top 10% NationallyRanked #111
- 2019Entered Top 5% NationallyRanked #111
- 2019Entered Top 1% NationallyRanked #111
- 2021$25M Cumulative Funding
- 2023$50M Cumulative Funding